HRT solely for prevention of CHD in postmenopausal women

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1302, 2001-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QOL effect of HRT in postmenopausal women

By  

Inpharma, Vol. 1, Iss. 1325, 2002-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

HRT use in postmenopausal women: guidelines

By  

Inpharma, Vol. 1, Iss. 1250, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

QOL effect of raloxifene, HRT in postmenopausal women

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 384, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Risedronate for prevention and treatment of osteoporosis in postmenopausal women

By Recker Robert R   Barger-Lux Janet  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 465-477

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory biomarkers predict CHD independent of HRT use

By  

Inpharma, Vol. 1, Iss. 1354, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite